Amos Hedt

Company: Perspective Therapeutics

Job title: Chief Business Officer

Seminars:

Next Generation Radiopharmaceuticals: How Good Can We Get? 11:00 am

Examining what is the current state of the art for radiopharmaceutical therapies Re-evaluating what are the characteristics of the “Ideal” Radiopharmaceutical Therapy Identifying what technologies are available to build such a therapyRead more

day: Day Two Discovery AM

Panel Discussion: Reflecting on the Past Year- Discussing Current Radiopharmaceutical Trends & Assessing Our Progress 8:30 am

Exploring PSMA updates and predictions for the future market of prostate cancer drugs Pricing and reimbursement considerations in a competitive market Discussing key future commercial challenges and opportunities for the field from advances in manufacturing to competitive demand and selection of radioisotopes, with emphasis on actinium-225, lead-212, copper-64Read more

day: Conference Day One